CStone Pharmaceuticals
CSPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,105 | $2,878 | $4,778 | $9,166 |
| - Cash | $388 | $997 | $559 | $743 |
| + Debt | $356 | $363 | $286 | $174 |
| Enterprise Value | $2,073 | $2,244 | $4,505 | $8,597 |
| Revenue | $407 | $464 | $481 | $244 |
| % Growth | -12.2% | -3.6% | 97.5% | – |
| Gross Profit | $240 | $304 | $278 | $137 |
| % Margin | 59% | 65.6% | 57.8% | 56.2% |
| EBITDA | -$26 | -$297 | -$850 | -$1,895 |
| % Margin | -6.4% | -64.1% | -176.5% | -777.6% |
| Net Income | -$91 | -$367 | -$903 | -$1,920 |
| % Margin | -22.4% | -79.2% | -187.5% | -787.8% |
| EPS Diluted | -0.072 | -0.29 | -0.77 | -1.65 |
| % Growth | 75.3% | 62.3% | 53.3% | – |
| Operating Cash Flow | -$343 | -$589 | -$612 | -$1,484 |
| Capital Expenditures | $0 | -$65 | -$102 | -$149 |
| Free Cash Flow | -$343 | -$654 | -$714 | -$1,633 |